Orchestra BioMed Holdings, Inc. (OBIO) Insider Trading Activity

NASDAQ$3.83
Market Cap
$216.26M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
103 of 888
Rank in Industry
72 of 508

OBIO Insider Trading Activity

OBIO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$2,321,435
10
91
Sells
$8,183
1
9

Related Transactions

PERCEPTIVE ADVISORS LLC10 percent owner
1
$1.93M
0
$0
$1.93M
RTW INVESTMENTS, LP10 percent owner
2
$275,701
0
$0
$275,701
Hochman David PSee Remarks
3
$90,290
0
$0
$90,290
Fain Eric Sdirector
1
$15,034
1
$8,183
$6,850
Sherman DarrenSee Remarks
1
$7,860
0
$0
$7,860
Taylor Andrew LawrenceChief Financial Officer
1
$5,100
0
$0
$5,100
Aryeh Jasondirector
1
$2,450
0
$0
$2,450

About Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

Insider Activity of Orchestra BioMed Holdings, Inc.

Over the last 12 months, insiders at Orchestra BioMed Holdings, Inc. have bought $2.32M and sold $8,183 worth of Orchestra BioMed Holdings, Inc. stock.

On average, over the past 5 years, insiders at Orchestra BioMed Holdings, Inc. have bought $1.25M and sold $116,875 worth of stock each year.

Highest buying activity among insiders over the last 12 months: PERCEPTIVE ADVISORS LLC (10 percent owner) — $1.93M. RTW INVESTMENTS, LP (10 percent owner) — $275,701. Hochman David P (See Remarks) — $90,290.

The last purchase of 5,000 shares for transaction amount of $20,350 was made by Hochman David P (See Remarks) on 2025‑11‑14.

List of Insider Buy and Sell Transactions, Orchestra BioMed Holdings, Inc.

2025-11-14PurchaseHochman David PSee Remarks
5,000
0.0086%
$4.07
$20,350
+9.14%
2025-09-19PurchaseAryeh Jasondirector
1,000
0.0019%
$2.45
$2,450
+64.34%
2025-08-25PurchaseSherman DarrenSee Remarks
3,000
0.0057%
$2.62
$7,860
+51.54%
2025-08-25PurchaseTaylor Andrew LawrenceChief Financial Officer
2,000
0.0037%
$2.55
$5,100
+51.54%
2025-08-25PurchaseFain Eric Sdirector
5,760
0.0109%
$2.61
$15,034
+51.54%
2025-08-21PurchaseHochman David PSee Remarks
6,000
0.0111%
$2.49
$14,940
+57.83%
2025-08-04PurchaseHochman David PSee Remarks
20,000
0.0583%
$2.75
$55,000
+45.15%
2025-08-01PurchasePERCEPTIVE ADVISORS LLC10 percent owner
700,000
1.642%
$2.75
$1.93M
+59.43%
2025-06-26SaleFain Eric Sdirector
2,683
0.0072%
$3.05
$8,183
+22.82%
2025-04-30PurchaseRTW INVESTMENTS, LP10 percent owner
49,900
0.1311%
$2.99
$149,201
+6.73%
2025-04-29PurchaseRTW INVESTMENTS, LP10 percent owner
50,000
0.1305%
$2.53
$126,500
+25.30%
2024-12-23PurchaseHochman David PSee Remarks
4,000
0.0107%
$4.66
$18,640
-30.92%
2024-12-19PurchaseTaylor Andrew LawrenceChief Financial Officer
1,000
0.0026%
$4.83
$4,830
-32.50%
2024-12-18PurchaseHochman David PSee Remarks
5,000
0.0145%
$4.91
$24,550
-31.93%
2024-09-25PurchaseHochman David PSee Remarks
7,500
0.0166%
$4.75
$35,630
-15.03%
2024-09-24PurchaseHochman David PSee Remarks
2,500
0.0057%
$4.91
$12,275
-13.23%
2024-09-10SaleSherman DarrenSee Remarks
6,904
0.0171%
$5.31
$36,660
-23.15%
2024-09-10SaleFain Eric Sdirector
1,800
0.0045%
$5.34
$9,612
-23.15%
2024-09-09SaleSherman DarrenSee Remarks
6,804
0.0174%
$5.48
$37,286
-22.05%
2024-09-09SaleFain Eric Sdirector
1,800
0.0046%
$5.43
$9,774
-22.05%
Total: 29
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
RTW INVESTMENTS, LP10 percent owner
8306063
14.7102%
$31.81M20
PERCEPTIVE ADVISORS LLC10 percent owner
5292556
9.3732%
$20.27M10
Sherman DarrenSee Remarks
926837
1.6414%
$3.55M15
Hochman David PSee Remarks
612822
1.0853%
$2.35M110
<0.0001%
Taylor Andrew LawrenceChief Financial Officer
482788
0.855%
$1.85M20
<0.0001%
Aryeh Jasondirector
108482
0.1921%
$415,486.0610
Fain Eric Sdirector
71709
0.127%
$274,645.4714
Little William ReedSee Remarks
307859
0.5452%
$1.18M10
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$8,708,580
93
-5.38%
$232.07M
$1,323,997
34
0.21%
$246.09M
$22,017,898
24
39.19%
$229.57M
$6,915,275
21
-32.61%
$251.22M
$110,580
16
14.52%
$246.36M
$245,302
15
-4.08%
$211.32M
$4,701,608
14
-4.34%
$238.85M
$1,037,470
13
78.00%
$204.87M
Orchestra BioMed Holdings, Inc.
(OBIO)
$170,425
10
-16.01%
$216.26M
$119,804,612
8
-17.22%
$184.91M
$145,296,407
8
-0.98%
$188.48M
$272,982
6
-28.53%
$223.58M
$8,286,963
6
3.09%
$231.97M
$6,049,986
4
-8.38%
$209.83M
$16,003,671
3
55.38%
$194.6M
$193,101
3
-25.20%
$193.71M
$37,067
3
-89.81%
$257.78M
$32,289,200
3
-5.46%
$204.11M
$1,516,110
3
8.05%
$210.19M

OBIO Institutional Investors: Active Positions

Increased Positions30+47.62%5M+27.95%
Decreased Positions25-39.68%460,485-2.5%
New Positions15New4MNew
Sold Out Positions12Sold Out243,656Sold Out
Total Postitions68+7.94%23M+25.45%

OBIO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Rtw Investments, Lp$35,799.0014.83%8.31M+<10%2025-09-30
Perceptive Advisors Llc$22,811.009.45%5.29M+700,000+15.24%2025-09-30
Vanguard Group Inc$6,387.002.65%1.48M+324,558+28.04%2025-09-30
Alyeska Investment Group, L.P.$5,885.002.44%1.37M+1MNew2025-09-30
Pathstone Holdings, Llc$4,336.001.8%1.01M+1MNew2025-09-30
Affinity Asset Advisors, Llc$3,135.001.3%727,272+727,272New2025-09-30
Blackrock, Inc.$2,863.001.19%664,333-17,016-2.5%2025-09-30
Knoll Capital Management, Llc$1,962.000.81%455,12800%2025-09-30
Price T Rowe Associates Inc /Md/$1,817.000.75%421,612-16,757-3.82%2025-09-30
Geode Capital Management, Llc$1,667.000.69%386,799+84,717+28.04%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.